These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34884269)

  • 21. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases.
    Pirillo A; Catapano AL
    Dis Markers; 2013; 35(5):413-8. PubMed ID: 24198442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kominami G; Kita T
    J Cardiol; 2010 Sep; 56(2):159-65. PubMed ID: 20605699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon.
    Caglar IM; Ozde C; Biyik I; Caglar FN; Akturk IF; Ugurlucan M; Karakaya O
    Arch Med Sci; 2016 Feb; 12(1):31-7. PubMed ID: 26925116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of sLOX-1 Level in Acute Coronary Syndromes Based on Thrombolysis in Myocardial Infarction Risk Score and Clinical Outcome.
    Mashayekhi S; Ziaee M; Garjani A; Sarbakhsh P; Ghaffari S
    J Emerg Med; 2018 Sep; 55(3):390-398. PubMed ID: 30049431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.
    Dey AK; Gaddipati R; Elnabawi YA; Ongstad E; Goyal A; Chung JH; Teague HL; Rodante JA; Sajja AA; Sorokin AV; Lateef SS; Aksentijevich M; Choi H; Reddy AS; Varghese NJ; Groenendyk J; Belur AD; Genovese L; Rivers JP; Lerman J; Kabbany MT; Harrington C; Ortiz J; Khalil N; Keel A; Baumer Y; Chen MY; Bluemke DA; Joshi AA; Kaplan MJ; Remaley AT; Playford MP; Karathanasis SK; Gelfand JM; Gupta R; Mehta NN
    JAMA Dermatol; 2020 Feb; 156(2):151-157. PubMed ID: 31746956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome.
    Kook H; Jang DH; Kim JH; Cho JY; Joo HJ; Cho SA; Park JH; Hong SJ; Yu CW; Lim DS
    Sci Rep; 2020 Nov; 10(1):20228. PubMed ID: 33214686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Int J Clin Exp Med; 2015; 8(11):21565-71. PubMed ID: 26885106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and microRNA-98 in Severity and Risk of Coronary Artery Disease.
    Sheikh MSA
    Balkan Med J; 2021 Jan; 38(1):13-22. PubMed ID: 33593717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.
    Mitsuoka H; Toyohara M; Kume N; Hayashida K; Jinnai T; Tanaka M; Kita T
    J Atheroscler Thromb; 2009 Oct; 16(5):586-93. PubMed ID: 19729872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers.
    Lubrano V; Del Turco S; Nicolini G; Di Cecco P; Basta G
    Lipids; 2008 Oct; 43(10):945-50. PubMed ID: 18781352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 as a biomarker of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Lin Q; Ba HJ; Dai JX; Sun J; Lu C; Chen MH; Chen XD; Cai JY
    Brain Behav; 2020 Feb; 10(2):e01517. PubMed ID: 31943892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Original contribution: sleeve gastrectomy reduces soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in patients with morbid obesity.
    Taskin HE; Kocael A; Kocael P; Zengin K; Al M; Sozer V; Buchwald JN; McGlennon TW; Uzun H
    Surg Endosc; 2022 Apr; 36(4):2643-2652. PubMed ID: 35044516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of sLOX-1 Levels and MR Characteristics of Culprit Plaques in Intracranial Arteries with Stroke Recurrence.
    Ren K; Jiang H; Li T; Qian C; Zhu L; Wang T
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 18 stimulates release of soluble lectin-like oxidized LDL receptor-1 (sLOX-1).
    Mitsuoka H; Kume N; Hayashida K; Inui-Hayashiada A; Aramaki Y; Toyohara M; Jinnai T; Nishi E; Kita T
    Atherosclerosis; 2009 Jan; 202(1):176-82. PubMed ID: 18514661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Plasma Levels of Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity.
    Stinson SE; Jonsson AE; Andersen MK; Lund MAV; Holm LA; Fonvig CE; Huang Y; Stankevič E; Juel HB; Ängquist L; Sørensen TIA; Ongstad EL; Gaddipati R; Grimsby J; Rhodes CJ; Pedersen O; Christiansen M; Holm JC; Hansen T
    J Am Heart Assoc; 2023 Feb; 12(3):e8145. PubMed ID: 36695299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LOX-1 and atherosclerotic-related diseases.
    Jin P; Cong S
    Clin Chim Acta; 2019 Apr; 491():24-29. PubMed ID: 30639239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study.
    Yokota C; Sawamura T; Watanabe M; Kokubo Y; Fujita Y; Kakino A; Nakai M; Toyoda K; Miyamoto Y; Minematsu K
    J Atheroscler Thromb; 2016 Oct; 23(10):1222-1226. PubMed ID: 27025681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes.
    Çoner A; Aydınalp A; Müderrisoğlu H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):96-103. PubMed ID: 30961517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke.
    Markstad H; Edsfeldt A; Yao Mattison I; Bengtsson E; Singh P; Cavalera M; Asciutto G; Björkbacka H; Fredrikson GN; Dias N; Volkov P; Orho-Melander M; Nilsson J; Engström G; Gonçalves I
    J Am Heart Assoc; 2019 Feb; 8(4):e009874. PubMed ID: 30744454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.